Cargando…
Oestrogen receptor alpha in pulmonary hypertension
AIMS: Pulmonary arterial hypertension (PAH) occurs more frequently in women with mutations in bone morphogenetic protein receptor type 2 (BMPR2) and dysfunctional BMPR2 signalling underpinning heritable PAH. We have previously shown that serotonin can uncover a pulmonary hypertensive phenotype in BM...
Autores principales: | Wright, Audrey F., Ewart, Marie-Ann, Mair, Kirsty, Nilsen, Margaret, Dempsie, Yvonne, Loughlin, Lynn, Maclean, Margaret R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4615797/ https://www.ncbi.nlm.nih.gov/pubmed/25765937 http://dx.doi.org/10.1093/cvr/cvv106 |
Ejemplares similares
-
Dexfenfluramine and the oestrogen-metabolizing enzyme CYP1B1 in the development of pulmonary arterial hypertension
por: Dempsie, Yvonne, et al.
Publicado: (2013) -
Development of pulmonary arterial hypertension in mice over-expressing S100A4/Mts1 is specific to females
por: Dempsie, Yvonne, et al.
Publicado: (2011) -
Obesity alters oestrogen metabolism and contributes to pulmonary arterial hypertension
por: Mair, Kirsty M., et al.
Publicado: (2019) -
Obesity, estrogens and adipose tissue dysfunction – implications for
pulmonary arterial hypertension
por: Mair, Kirsty M., et al.
Publicado: (2020) -
Serotonin Signaling Through the 5-HT(1B) Receptor and NADPH Oxidase 1 in Pulmonary Arterial Hypertension
por: Hood, Katie Y., et al.
Publicado: (2017)